Investment
Features
FeesSafety
Academy
More
Pluang+

Compare TG Therapeutics Inc (TGTX) vs Verizon Communications Inc (VZ) Price & Performance

TG Therapeutics IncTrade
Verizon Communications IncTrade

Price performance (Past 24H)

Key statistics

TG Therapeutics Inc vs Verizon Communications Inc — how do they compare? TG Therapeutics Inc trades at $54.06 (market cap $8.26B), while Verizon Communications Inc trades at $43.73 (market cap $181.64B). The key difference: Verizon Communications Inc is far larger — about 22× TG Therapeutics Inc's market cap, and Verizon Communications Inc pays a 6.51% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.

TGTXVZ
Market Cap
$8.26B$181.64B
Sector
HealthMedia
52-Week High
$59.06$51.38
52-Week Low
$26.39$38.40
Enterprise Value
$8.50B$369.14B
Volume
22,584,735
Dividend Yield
6.51%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About TG Therapeutics Inc

TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.

Read more on TGTX

About Verizon Communications Inc

Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.

Read more on VZ